TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $56 | -100.0% | 37,452 | -76.4% | 0.01% | -89.8% |
| Q1 2022 | $438,000 | +26.2% | 158,593 | +113.2% | 0.06% | +34.1% |
| Q4 2021 | $347,000 | -44.6% | 74,402 | +1.1% | 0.04% | -31.2% |
| Q3 2021 | $626,000 | +19.5% | 73,579 | +130.4% | 0.06% | +8.5% |
| Q2 2021 | $524,000 | +137.1% | 31,942 | +218.6% | 0.06% | +59.5% |
| Q1 2021 | $221,000 | +5.2% | 10,025 | +47.7% | 0.04% | +8.8% |
| Q4 2020 | $210,000 | – | 6,788 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |